Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sara, Ortiz Pérez"'
Autor:
Susana Cortijo-Cascajares, Ana Cristina Cercós-Lletí, Sara Ortiz-Pérez, José Manuel Caro-Teller, José Miguel Ferrari-Piquero
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:290-298
Objective To study immune-related adverse events (irAEs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab, as well as to assess whether these reactions could be predictors of further effectiveness of therapy. Methods Retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc0af0e3f68d4ce64bb4f38d2652ac3
https://doi.org/10.1177/10781552211067429
https://doi.org/10.1177/10781552211067429
Autor:
Sara Ortiz-Pérez, José Manuel Caro-Teller, Maria Arrieta-Loitegui, Rafael San Juan-Garrido, Jose Miguel Ferrari-Piquero, Francisco López-Medrano
Publikováno v:
Eur J Hosp Pharm
Objectives Dalbavancin is approved for the treatment of complicated skin and soft tissue infections. However, there is growing evidence that other gram-positive infections could be treated with this antibiotic. A study was undertaken in a tertiary ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ad7eab1d4c04ea87d84297680d141d
https://doi.org/10.1136/ejhpharm-2020-002315
https://doi.org/10.1136/ejhpharm-2020-002315
Autor:
Sara, Ortiz Pérez, José Manuel, Caro Teller, Carmen, García Muñoz, Paola, Herraiz Robles, Fernando, Lozano Morillo, José Luis, Pablos Álvarez, José Miguel, Ferrari Piquero
Publikováno v:
Revista espanola de salud publica. 95
Intravenous (IV) tocilizumab has been used to stop the inflammatory phase of SARS-CoV-2 infection. To preserve the largest number of IV units for this use, the Spanish Agency for Medicines and Health Products (AEMPS) carried out a controlled supply o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03a3d19ba943d9b71fda41e596c30cdf
https://pubmed.ncbi.nlm.nih.gov/34803159
https://pubmed.ncbi.nlm.nih.gov/34803159